Opioid Agonist Therapy for Opioid Use Disorder
Expanding Medication-Assisted Therapies in Central Asia
Recruiting
N/A
Interventional Study
Opioid Use Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 900 (estimated)
- Sponsor
- Yale University · Other
Who this trial is looking for
This trial is looking for people with opioid dependence to help improve treatment options in Central Asia. Participants will share their experiences or be involved in assessments related to opioid agonist therapy.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older
- I meet the criteria for opioid dependence
- I have never received opioid agonist therapy or I have been on it for less than 90 days
- I currently work as an opioid agonist therapy delivery professional
You may not be able to join if
- I am not willing to provide consent
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Central Asia (CA) represents the most rapidly growing HIV epidemic region worldwide, concentrated in people who inject drugs (PWID) and their sexual partners, and scaling up opioid agonist therapies (OAT) in this region is the most cost-effective strategy to prevent new HIV infections, and more effective when combined with antiretroviral therapy (ART). The investigators propose to use the Network …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
i. Aim 1: The inclusion criteria for Aim 1 Consists of:
1. Quantitative surveys for PWID
1. 18 years or older
2. Meeting DSM-V criteria for opioid dependence
3. Be either treatment naïve and seeking OAT or be on OAT for \< 90 days
2. Organizational Assessments for OAT…
Contacts